Winston Tan, MD

Articles by Winston Tan, MD

Dr. Tan on Imaging Modalities in Prostate Cancer

ByWinston Tan, MD

August 14th 2019

Winston Tan, MD, hematologist/oncologist, Mayo Clinic, discusses imaging modalities in prostate cancer.

Dr. Tan Discusses the FDA Approval of Darolutamide in M0CRPC

ByWinston Tan, MD

July 31st 2019

Winston Tan, MD, hematologist/oncologist, Mayo Clinic, discusses the FDA approval of darolutamide (Nubeqa) in nonmetastatic castration-resistant prostate cancer (M0CRPC).

Latest Updated Articles

Dr. Tan Discusses the FDA Approval of Darolutamide in M0CRPC
July 31st 2019
Dr. Tan on Imaging Modalities in Prostate Cancer
August 14th 2019

Winston Tan, MD

Articles by Winston Tan, MD

Dr. Tan on Imaging Modalities in Prostate Cancer

Dr. Tan Discusses the FDA Approval of Darolutamide in M0CRPC

Latest Updated Articles

Trending on OncLive

Long-Term Data Refine the Role of Immunotherapy Across Early-Stage NSCLC Settings

Dr Tarantino on the Evolution of TROP2-Directed ADCs in First-Line TNBC

Dr Hurvitz on Updated PFS Data From the SERENA-6 Trial in Breast Cancer

Ris-Rez Meets Phase 3 Efficacy End Point for R/R Osteosarcoma

Comprehensive Molecular Testing Powers Biomarker-Driven Care in Advanced NSCLC